• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov14
Moleculin Biotech released FY2025 9 Months Earnings on November 13 (EST), with actual revenue of USD 0 and EPS of USD -2.4608
04:00
Moleculin Biotech released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.6808 (forecast USD -0.2633)
04:00
Nov12
Moleculin Biotech Enters into Research Agreement with UNC Chapel Hill for Annamycin Pancreatic Cancer Therapy
13:38
Oct29
Moleculin Biotech Obtains Annamycin Patent in Australia
12:36
Oct23
Moleculin Biotech Launches Annamycin Clinical Trial for Late-Stage Pancreatic Cancer
12:01
Sep25
Moleculin Biotech Receives Patent Allowance Notice for Liposomal Annamycin
12:36

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -25.4 M, EPS -0.6808

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -17.28 M, EPS -1.0911

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.436 M, EPS -0.6888

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy